1. Preventing Venous Thromboembolism Participating Hospital Survey

2. Why did we do the survey?
Consortium baseline of VTE prophylaxis in medicine patients
Data abstraction logistics
EMR v. Paper
CPOE
Ability to Filter
Billing Data Access
Requirements/Contacts for audit process
Request site-specific documents related to VTE risk assessment

3. Response Survey distributed to 13 sites on 6/28
12 sites responded
1 site unsure of ongoing participation
5 additional sites received survey on 7/19
2 sites responded
Expect response from 3 remaining

4. VTE Assessment & Guidelines
93% “have a specific process for assessing VTE risk, on admission, in medical inpatients”
93% “have a protocol or guideline for pharmacological VTE prophylaxis”
77% Generalized to All Patients
23% Medicine Patients and Surgical Patients
86% “have a protocol or guideline for mechanical VTE prophylaxis”
75% Generalized to All Patients
17% Medicine Patients and Surgical Patients
8% Medicine Patients
50% have VTE Committee in place currently

5. VTE Pharmacological Prophylaxis

6. Pharmacological Prophylaxis (cont.)
Warfarin?
71% of sites reported warfarin use
Responding for non-medicine patients?

7. VTE Mechanical Prophylaxis

8. Electronic v. Paper 14% all electronic medical record
21% all paper medical record
65% mix of both
36% computerized physician order entry
64% no CPOE

9. Selection & Sampling Process
Eligible Cases = Medicine Admissions
Exclusions:
Pregnant
Under age 18
Admitted for surgery
Admitted for palliative care
Discharged within 24 hours of admission
Admitted to ICU within 24 hours of admission
Admitted for and received treatment for presumed VTE
VTE in 6 months prior to admission
8-day sampling cycle with 20 eligible cases/cycle
i.e. cycle 1 starts Monday, cycle 2 starts Tuesday, etc.

10. Filtering Process 100% ability to electronically filter
Anticipate any problems identifying eligible patients?
100% capable of doing so in a “timely fashion”
What does timely mean?
How long will the lag be at your site?
Will provide sample filtering process
Based on process will ask sites to indicate lag time

11. Use of Billing Data 77% access to billing data for abstractor
23% no access
Universal Billing Statement (UB-04)
3 – 30 days to produce
Average = 9.5 days
How should billing data be used?

12. Questions . . .
About Completed Survey?
That should have been asked?